Cargando…

Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia

Amiodarone (AMD) and nifekalant (NIF) are used in the treatment of ventricular fibrillation or tachycardia; however, only few studies have been conducted on their efficacies. Therefore, a meta-analysis was conducted. Relevant sources were identified from PubMed, Cochrane Central Register of Controll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Shiho, Zamami, Yoshito, Imai, Toru, Tanaka, Satoshi, Koyama, Toshihiro, Niimura, Takahiro, Chuma, Masayuki, Koga, Tadashi, Takechi, Kenshi, Kurata, Yasuko, Kondo, Yutaka, Izawa-Ishizawa, Yuki, Sendo, Toshiaki, Nakura, Hironori, Ishizawa, Keisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627292/ https://www.ncbi.nlm.nih.gov/pubmed/28978927 http://dx.doi.org/10.1038/s41598-017-13073-0

Ejemplares similares

Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR‐ABL inhibitor use by using an adverse drug event reporting database
por: Okada, Naoto, et al.
Publicado: (2018)

Intraoperative pulseless ventricular tachycardia after Ondansetron
por: Samanta, Sukhen, et al.
Publicado: (2014)

Comparison of nifekalant and amiodarone for resuscitation after cardiopulmonary arrest due to shock-resistant ventricular fibrillation
por: Harayama, N, et al.
Publicado: (2011)

Evaluation of pharmaceutical lifesaving skills training oriented pharmaceutical intervention
por: Zamami, Yoshito, et al.
Publicado: (2016)

Preventive Effects of Quercetin against the Onset of Atherosclerosis-Related Acute Aortic Syndromes in Mice
por: Kondo, Masateru, et al.
Publicado: (2020)

Long-term nifekalant use in a patient with dilated cardiomyopathy and recurrent ventricular tachycardia
por: Xiao, Hongyan, et al.
Publicado: (2022)

Search for Therapeutic Agents for Cardiac Arrest Using a Drug Discovery Tool and Large-Scale Medical Information Database
por: Zamami, Yoshito, et al.
Publicado: (2019)

Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation
por: Harayama, Nobuya, et al.
Publicado: (2014)

Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia
por: Van Herendael, Hugo, et al.
Publicado: (2010)

Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis( )
por: Chuma, Masayuki, et al.
Publicado: (2022)

Drug-Repositioning Approaches Based on Medical and Life Science Databases
por: Zamami, Yoshito, et al.
Publicado: (2021)

Congenital Adrenal Hyperplasia Presenting as Pulseless Ventricular Tachycardia in a Neonate
por: Manzoor, Nida, et al.
Publicado: (2019)

Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest
por: Niimura, Takahiro, et al.
Publicado: (2017)

Effects of 5‐HT(₃) receptor antagonists on cisplatin‐induced kidney injury
por: Goda, Mitsuhiro, et al.
Publicado: (2021)

Comparison of clinical outcomes between patients with pulseless-ventricular tachycardia and ventricular fibrillation in out-of-hospital cardiac arrest
por: Kato, Yuta, et al.
Publicado: (2021)

Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis
por: Horinouchi, Yuya, et al.
Publicado: (2018)

Impact of Amiodarone Therapy on the Ablation Outcome of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Lin, Chin-Yu, et al.
Publicado: (2022)

Evaluation of potential complication of interstitial lung disease with abemaciclib and palbociclib treatments
por: Nawa, Hideki, et al.
Publicado: (2021)

Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: a observational cohort study
por: Grmec, Stefek, et al.
Publicado: (2006)

Pediatric Pulseless Ventricular Tachycardia: A Simulation Scenario for Fellows, Residents, Medical Students, and Advanced Practitioners
por: Cashen, Katherine, et al.
Publicado: (2016)

Extracorporeal Cardiopulmonary Resuscitation (ECPR) for Out-of-Hospital Cardiac Arrest due to Pulseless Ventricular Tachycardia/Fibrillation
por: Boudoulas, Konstantinos Dean, et al.
Publicado: (2020)

Effect of nifekalant for out-of–hospital cardiac arrest with shock-resistant ventricular fibrillation
por: Toyama, H, et al.
Publicado: (2004)

Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice
por: Ikeda, Yasumasa, et al.
Publicado: (2017)

Investigation of drugs affecting hypertension in bevacizumab‐treated patients and examination of the impact on the therapeutic effect
por: Yagi, Kenta, et al.
Publicado: (2020)

Discovery of preventive drugs for cisplatin‐induced acute kidney injury using big data analysis
por: Kanda, Masaya, et al.
Publicado: (2022)

Evaluation of Potential Complications of Interstitial Lung Disease Associated With Antiandrogens Using Data From Databases Reporting Spontaneous Adverse Effects
por: Nawa, Hideki, et al.
Publicado: (2021)

Difference in end-tidal CO(2 )between asphyxia cardiac arrest and ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest in the prehospital setting
por: Grmec, Štefek, et al.
Publicado: (2003)

Succinylcholine Administration and Resultant Pulseless Ventricular Tachycardia: A Case Report of Communication Breakdown During an Emergent Intubation
por: Toy, Jake, et al.
Publicado: (2020)

Valproic acid treatment attenuates cisplatin‐induced kidney injury by suppressing proximal tubular cell damage
por: Yoshioka, Toshihiko, et al.
Publicado: (2023)

Comparison of Hemorrhagic Risk between Prasugrel and Clopidogrel: a Retrospective Study using Adverse Drug Event Reporting Databases
por: Hagiwara, Hiromi, et al.
Publicado: (2020)

Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects
por: Nawa, Hideki, et al.
Publicado: (2022)

Nifekalant versus Amiodarone for Out-Of-Hospital Cardiac Arrest with Refractory Shockable Rhythms; a Post Hoc Analysis
por: Funakoshi, Hiraku, et al.
Publicado: (2022)

The dynamic pattern of end-tidal carbon dioxide during cardiopulmonary resuscitation: difference between asphyxial cardiac arrest and ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest
por: Lah, Katja, et al.
Publicado: (2011)

Negative lusitropic property of nifekalant identified using ventricular pressure-volume loop analyses in anesthetized monkeys
por: Ishizaka, Tomomichi, et al.
Publicado: (2018)

Use of Intravenous Amiodarone in the Treatment of Nifekalant-Resistant Arrhythmia: A Review of 11 Consecutive Cases with Severe Heart Failure
por: Nakagawa, Koji, et al.
Publicado: (2011)

Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study
por: Okada, Naoto, et al.
Publicado: (2020)

Chronic Tear Deficiency Sensitizes Transient Receptor Potential Vanilloid 1-Mediated Responses in Corneal Sensory Nerves
por: Masuoka, Takayoshi, et al.
Publicado: (2020)

Ventricular Tachycardia
por: Menon, Rohit, et al.
Publicado: (2023)

Ventricular tachycardia or supraventricular tachycardia?
por: Alasti, Mohammad, et al.
Publicado: (2022)

Pharmacy Students’ Knowledge and Attitude toward Registration Trials and Clinical Research: A Survey in a Japanese University Hospital
por: Ise, Natsuko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rjiearfvbsbr3sn3ns89jdhnlf